Dr. Jeffrey Givand is currently a Director within the Device Development group at Merck. His primary area of focus is combination product development for parenteral delivery of biopharmaceutical formulations. The scope of his work includes management of combination product development activities ranging from primary container development, injection device concepting, patient market research, molding and assembly development, design verification and design validation through human factors evaluations.

Jeffrey holds a bachelor’s degree in Chemical Engineering from the University of Virginia and master’s and doctoral degrees in Chemical Engineering from the Georgia Institute of Technology.